Back

Eicosapentaenoic acid (EPA) treatment increased the ratio to arachidonic (EPA/AA) and reduced adhesion molecule expression in vascular endothelium during inflammation

13 April 2023 (10:45 - 10:55)
Organised by:
Congress Presentation Part of: Primary Care and Risk Factor Management 1 Lipids, Metabolism EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Doctor Samuel Sherratt

Elucida Research LLC, Beverly (United States of America)

3 More presentations in this session

Presentation thumbnail
The association between circulating lipoprotein subfractions and lipid content in coronary atheromatous plaques assessed by near-infrared spectroscopy
Miss J. Saether (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
Eicosapentaenoic acid (EPA) reduced expression of neutrophil activation proteins in endothelial cells during challenge with angiotensin II (Ang II) and cytokines
Mr S. Sherratt (Beverly, US)
Abstract Slides Video
Presentation thumbnail
Klotho and FGF23 proteins levels and occurrence of myocardial infarction in patients with acute coronary syndrome
Doctor A. Olejnik (Wroclaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Primary Care and Risk Factor Management 1
Video

The Event

Event poster

ESC Preventive Cardiology 2023

13 April 2023 10:45 CET
You may be interested in
thumbnail
Congress Presentation
Perspectives on the results of recent clinical outcome trials with icosapent ethyl
thumbnail
Congress Presentation
Eicosapentaenoic acid (EPA) modulates inflammasome activation in monocyte-derived macrophages isolated from individuals with and without established atherosclerotic cardiovascular disease (ASCVD).
thumbnail
Congress Presentation
Eicosapentaenoic acid (EPA) inhibited lipoprotein(a) [Lp(a)] oxidation and its effects on expression of oxidative stress and pro-inflammatory proteins in endothelial cells

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources